SCHEMBL29566848

SCHEMBL29566848

CC(C)c1ccccc1-c1cc(OCC2CC2)nc(NS(=O)(=O)c2cccc(N)c2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ CCNA2 P20248 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ CCNA1 P78396 1/20 0.37
▸ MAPT P10636 1/20 0.36
▸ PIK3C2B O00750 1/20 0.36
▸ PIK3C2G O75747 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HTR6 P50406 3/20 0.35
▸ HTR1A P08908 6/20 0.34
▸ HTR7 P34969 6/20 0.34
▸ DRD2 P14416 2/20 0.34
▸ CYP19A1 P11511 1/20 0.34
▸ F2 P00734 1/20 0.34
▸ ADRA1D P25100 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ ADRA1A P35348 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26806781 1.00 POLB (0.37) POLBCDK1CCNA2CDK2CCNA1
SCHEMBL26806784 0.89 POLB (0.41) POLBMAPTPIK3C2BPIK3C2GSMN1; SMN2
SCHEMBL29566361 0.86 LMNA (0.41) MAPTALDH1A1CYP19A1
SCHEMBL26806783 0.85 POLB (0.41) POLBMAPTPIK3C2BPIK3C2GSMN1; SMN2
SCHEMBL26806794 0.85 POLB (0.38) POLBMAPTPIK3C2BPIK3C2GSMN1; SMN2
SCHEMBL26806787 0.85 PTGS1 (0.40) POLBMAPTPIK3C2BPIK3C2GSMN1; SMN2
SCHEMBL26806726 0.84 POLB (0.43) POLBMAPTPIK3C2BPIK3C2GSMN1; SMN2
SCHEMBL24309523 0.83 POLB (0.36) POLBMAPTPIK3C2BPIK3C2GSMN1; SMN2
SCHEMBL29566755 0.83 POLB (0.36) POLBMAPTPIK3C2BPIK3C2GSMN1; SMN2
SCHEMBL26806791 0.83 POLB (0.36) POLBMAPTPIK3C2BPIK3C2GSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback